Ann: Pause in Trading, page-38

Hi @katy,

Thanks for your informative post. Yes that embargo that has kept results under wraps, which is nothing unusual in Biotechs.

I think you are right that trial results are implied to be positive, but the company cannot disclose until that embargo is lifted.

I guess we already knew this with the Janssen collaboration moving into the second phase (or it would have been canned), that was a massive clue from March, so assumed knowledge for us.

I think in particular this statement from the presentation, page 12:

”Upcoming FDA Regulatory approval process should be accelerated by using the Janssen/PromarkerD data.”

I got really excited yesterday when I saw the pause in trading & where the SP was at haha! Alas an ASX query, & I hope there is no bother with the ASX, PIQ is not a dodgy stock.


Thanks for your comments re DXB also. Our turn here next.

Not long to wait for results now everyone!

GLTAH